articleStartups

    Deep-Tech Series C Funding: Why Strategics Lead 2026

    Strategic corporates and government-backed investors now co-anchor deep-tech Series C rounds to secure supply-chain advantage and defensible IP, outpacing traditional PE capital in the race for geopolitical resilience.

    BySarah Mitchell
    ·10 min read
    Editorial illustration for Deep-Tech Series C Funding: Why Strategics Lead 2026 - Startups insights

    Deep-Tech Series C Funding: Why Strategics Lead 2026

    Liquid Instruments' $50 million Series C round, co-led by Keysight Technologies and Australia's National Reconstruction Fund Corporation in May 2026, marks a decisive shift: strategic corporates and government-backed vehicles now co-anchor later-stage deep-tech rounds to lock in supply-chain advantage, not just financial returns. Traditional PE's passive capital can't compete when the prize is defensible IP and geopolitical resilience.

    Angel Investors Network provides marketing and education services, not investment advice. Consult qualified legal, tax, and financial advisors before making investment decisions.

    What Makes Liquid Instruments' Series C Different?

    Liquid Instruments, an Australian company that builds software-defined test and measurement tools, announced its Series C on May 2, 2026. The round was co-led by Keysight Technologies—a $25 billion market-cap test equipment giant—and the National Reconstruction Fund Corporation, a government-backed investment vehicle created to rebuild domestic manufacturing capacity. That pairing tells you everything about where deep-tech funding is headed.

    Keysight doesn't write checks for IRR. It writes them to control roadmap. When a market-leader invests at Series C, it's securing early access to IP that could obsolete its own product lines or strengthen its competitive moat. The National Reconstruction Fund, meanwhile, explicitly prioritizes supply-chain sovereignty. Its mandate isn't maximizing returns—it's ensuring critical technology stays onshore and scales domestically.

    This isn't venture capital. It's strategic positioning disguised as growth equity.

    Why Are Strategic Corporates Co-Leading Series C Rounds in 2026?

    Traditional venture capital follows a playbook: write the check, add to the board, drive toward an exit in five to seven years. That model breaks down when the acquirer is already in the cap table. Strategic CVCs operate on a different clock. They invest to secure IP access, block competitors, or build optionality around M&A—not just to harvest a multiple.

    Keysight's involvement in Liquid Instruments gives it a front-row seat to software-defined instrumentation. If Liquid Instruments' platform displaces legacy hardware-based oscilloscopes and spectrum analyzers, Keysight either acquires the company or integrates its tools into its own ecosystem. Either way, Keysight wins. A pure financial investor gets diluted and hopes for a buyer. Keysight is the buyer.

    Government-backed funds add another layer. The National Reconstruction Fund exists because Australia recognized it had ceded too much advanced manufacturing to China and Taiwan. Deep-tech tools—semiconductors, photonics, quantum sensors—are now strategic assets. Countries that control their production control their defense capabilities. That's why government-backed investment vehicles are writing nine-figure checks into technologies that traditional VCs would've passed on as too slow or too niche.

    How Does This Change Series C Valuations and Terms?

    Strategic investors don't optimize for valuation multiples. They optimize for control and optionality. That creates tension in pricing. A CVC willing to pay a 20% premium over the last round isn't irrational—it's buying insurance against disruption. But founders who assume every investor thinks like a VC will leave money on the table or accept terms that lock them into a single exit path.

    Here's what changes when strategics co-lead your Series C:

    • Rights of first refusal (ROFR) on M&A. Keysight likely secured language giving it the right to match any acquisition offer. That's standard in corporate venture deals. It caps your upside unless you're willing to run a full auction—and even then, the ROFR lets the strategic investor force a negotiation.
    • Board composition tilts toward product roadmap control. Strategic investors push for seats or observers who influence product decisions. They're not passive—they want to ensure your R&D aligns with their ecosystem. That's valuable if your goals align. It's suffocating if they don't.
    • Liquidation preferences stack differently. Government-backed funds often accept standard 1x non-participating prefs because their mandate is job creation and supply-chain resilience, not maximizing proceeds. Strategic CVCs, however, sometimes negotiate participating prefs or ratchets tied to revenue milestones. Read the fine print.

    Founders in deep-tech need to model both the financial and strategic outcomes. A strategic-led Series C often trades higher near-term valuation for narrower exit optionality. That's fine if the strategic is your preferred acquirer. It's a trap if you wanted to stay independent or sell to a competitor.

    What Does "Supply-Chain Defensibility" Mean in Practice?

    Supply-chain defensibility is the new moat. It's not enough to build a better product—you need to control the inputs, the manufacturing process, and the distribution channels in a way that makes you irreplaceable. That's why Keysight and the National Reconstruction Fund co-led this round. Liquid Instruments builds tools that replace racks of expensive, single-purpose hardware with software-defined platforms. If those platforms become the standard for R&D labs, semiconductor fabs, and defense contractors, whoever controls Liquid Instruments controls a chokepoint in critical infrastructure.

    The playbook mirrors what happened in semiconductors. Taiwan Semiconductor Manufacturing Company (TSMC) didn't just win on process technology—it won by becoming the only foundry capable of producing leading-edge chips at scale. Once Apple, Nvidia, and AMD were locked into TSMC's 5nm and 3nm nodes, switching became impossible. TSMC controlled the supply chain. Governments noticed. The CHIPS Act in the US and the National Reconstruction Fund in Australia both exist to rebuild domestic capacity for exactly that reason.

    Liquid Instruments operates in a smaller market, but the logic is identical. If its software-defined instruments become the standard, switching costs skyrocket. Labs won't retrain staff, recertify workflows, or revalidate compliance just to save a few percentage points on hardware costs. Lock-in is the goal. Strategic investors pay for that lock-in early.

    Why Traditional PE Funds Are Losing Later-Stage Deep-Tech Deals

    >Private equity firms optimize for leverage, operational improvements, and financial engineering. That works in mature, cash-flowing businesses. It fails in deep-tech, where the value is IP, talent, and ecosystem positioning—not EBITDA. A PE fund can't credibly promise Liquid Instruments access to Keysight's customer base or integration into defense procurement pipelines. A strategic investor can.

    PE funds also operate on compressed timelines. They want an exit in three to five years. Deep-tech companies often need seven to ten years to reach the scale where a strategic acquirer will pay a premium. That mismatch makes PE a poor fit for Series C and beyond unless the company is already generating significant revenue and has a clear path to profitability within the fund's hold period.

    The data backs this up. According to PitchBook, corporate venture capital participation in Series C rounds increased from 22% in 2019 to 38% in 2025. Government-backed funds, once a negligible share of venture activity, now represent 12% of all later-stage deep-tech rounds globally. Traditional PE participation in the same category dropped from 31% to 19% over the same period. The market is voting. Strategic capital wins when the asset is IP and supply-chain control.

    How Should Founders Navigate Strategic-Led Rounds?

    Taking money from a strategic investor is a one-way door. Once Keysight is on your cap table, every competitor will assume you're a Keysight acquisition target. That closes off alternative exits unless you're willing to fight through ROFR clauses and navigate conflicts of interest. Here's how to avoid getting trapped:

    Run a true dual-track process. Don't let the strategic investor believe they're the only option. Bring in at least one independent institutional investor—Sequoia, a16z, a top-tier growth fund—who can credibly compete. That forces the strategic to price fairly and limits their ability to impose onerous terms. Simultaneous closings with multiple lead investors create competitive tension and preserve optionality.

    Negotiate board composition carefully. Strategic investors will push for a board seat or observer rights. Accept the observer seat, not the voting seat, unless they're investing at a valuation that justifies it. Board seats give them veto power over future financing, M&A, and strategic pivots. Observer rights let them stay informed without controlling your decisions.

    Cap ROFR windows and match rights. If you agree to a right of first refusal, limit it to 30 days and require the strategic investor to match on all terms—not just price. A strategic buyer offering stock, earnouts, and employment agreements is hard to match with cash. That creates an escape hatch if you want out.

    Preserve founder liquidity. Strategic-led rounds often defer founder liquidity until an exit. That's a trap. Negotiate at least 10-15% secondary for founders in the Series C. If the strategic investor is bullish enough to lead, they should be willing to let you take some chips off the table. Secondary liquidity also signals confidence—you're not cashing out, you're de-risking while staying committed.

    Founders who treat strategic investors like passive capital get trapped. Founders who negotiate knowing the strategic is also a future acquirer get terms that preserve optionality.

    What Does This Mean for Angel and Early-Stage Investors?

    If you're an angel investor or seed-stage fund in deep-tech, strategic interest at Series C is your exit signal. The moment Keysight leads a round, the acquisition clock starts ticking. That's good news if you're looking to liquidate in the next 24-36 months. It's bad news if you believed the company would stay independent.

    Early investors should also pay attention to how strategic capital reshapes cap tables. Strategic CVCs often invest at higher valuations than traditional VCs, which means your pro-rata follow-on rights become more expensive to exercise. If you don't have deep pockets or a fund structure that can deploy into later rounds, you'll get diluted. That's why understanding how Series B and Series C rounds differ is critical for early-stage investors planning their follow-on strategy.

    The flip side: if you're investing in deep-tech at seed, prioritize companies in sectors where strategic interest is high. Software-defined tools, quantum computing, advanced materials, biotech—these are all categories where corporates are building or acquiring rather than competing on organic R&D. Position yourself in rounds where a Keysight, Siemens, or Lockheed Martin will eventually show up. Your multiple comes from their urgency, not just the company's growth.

    Will This Trend Accelerate or Reverse?

    Strategic and government-backed capital in deep-tech isn't a trend—it's a structural shift. The factors driving it aren't going away. Geopolitical competition between the US, China, and Europe over advanced manufacturing and AI infrastructure is intensifying. Defense budgets are rising. Supply-chain resilience is now a CEO-level priority at every Fortune 500 company.

    That means more Keysight-style Series C rounds, more National Reconstruction Fund-style government co-investments, and more cap tables where the lead investor is also the most likely acquirer. Traditional venture capital will still play a role—seed and Series A rounds in deep-tech still need patient, risk-tolerant capital that strategics won't provide. But by Series C, the game changes. The question is no longer "Can this company grow?" It's "Can this company become strategically indispensable?"

    Liquid Instruments answered that question. Keysight wrote the check. The rest of the deep-tech market is taking notes.

    Frequently Asked Questions

    What is a strategic corporate venture capital (CVC) investor?

    A strategic CVC is the investment arm of a large corporation that invests in startups to gain access to technology, talent, or market positioning—not just financial returns. These investors often become future acquirers of the companies they fund, creating conflicts and opportunities that pure financial investors don't face.

    Why do government-backed funds invest in deep-tech startups?

    Government-backed funds like Australia's National Reconstruction Fund invest to secure domestic supply chains, create jobs, and ensure critical technologies remain onshore. Their mandates prioritize economic resilience and national security over maximizing financial returns, allowing them to fund longer-term projects that traditional VCs avoid.

    How does a strategic investor's ROFR affect exit options?

    A right of first refusal (ROFR) gives the strategic investor the right to match any acquisition offer before the company can accept it. This limits exit options by forcing the company to negotiate with the strategic investor first, often resulting in lower acquisition prices or narrower buyer pools since competitors know they must outbid the strategic holder.

    Should founders accept strategic investment at Series C?

    Founders should accept strategic investment only if they're comfortable narrowing their exit options and aligning their roadmap with the strategic investor's priorities. The trade-off is access to customers, distribution, and higher valuations in exchange for reduced independence and potential lock-in to a single acquirer.

    What percentage of Series C rounds include strategic investors in 2026?

    Corporate venture capital participation in Series C rounds reached 38% in 2025 according to PitchBook data, up from 22% in 2019. Government-backed funds now represent 12% of later-stage deep-tech rounds globally, reflecting the shift toward strategic and sovereign capital in critical technology sectors.

    How do strategic Series C rounds differ from traditional VC rounds?

    Strategic Series C rounds prioritize supply-chain control, IP access, and M&A optionality over pure financial returns. Terms often include board seats, ROFR clauses, and product roadmap alignment requirements that traditional VCs don't impose. Valuations may be higher, but exit flexibility is lower.

    What should early-stage investors do when a strategic leads Series C?

    Early-stage investors should treat strategic involvement as an exit signal and prepare for an acquisition within 24-36 months. They should also evaluate whether to exercise pro-rata rights at the higher Series C valuation or begin positioning for liquidity through secondary sales or the eventual M&A event.

    Are traditional PE firms still competitive in deep-tech Series C rounds?

    Traditional PE firms are losing ground in deep-tech Series C rounds because they can't offer the strategic value—customer access, supply-chain integration, government relationships—that corporate and sovereign investors provide. PE participation in later-stage deep-tech rounds dropped from 31% to 19% between 2019 and 2025 according to PitchBook.

    Ready to connect with investors who understand deep-tech? Apply to join Angel Investors Network.

    Looking for investors?

    Browse our directory of 750+ angel investor groups, VCs, and accelerators across the United States.

    Share
    S

    About the Author

    Sarah Mitchell